Vaccine Therapy in Treating Patients With Unresectable Metastatic Melanoma

Clinical trial NCT00004148 · COMPLETED

Trial details

NCT number: NCT00004148
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Melanoma (Skin)

Start date: 1999-10-01
Primary completion: 2006-04-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.